For more than a decade, Amgen scientists have applied innovative research to advance important new therapies for grievous illnesses. Amgen’s heritage in cutting-edge molecular biology has led to the development of protein therapeutics that have transformed the management of anemia, inflammation and cancer.
More recently, Amgen has assembled a multidisciplinary group of chemists and biologists who together approach the challenge of drug discovery using multiple potential therapeutic modalities. This approach allows us to choose the best target for attacking a disease and to use the modality most likely to affect that target. The research program has, yielded a heightened understanding of human disease, and innovative new approaches to improving human health.
Our Research and Development (R&D) engine is powered by dedicated, creative scientists who are attracted to Amgen by our intellectual vigor, our commitment to world-class research and most importantly, by the many opportunities we offer to make a dramatic difference in the lives of patients.